Cargando…
Altered monocyte activation markers in Tourette’s syndrome: a case–control study
BACKGROUND: Infections and immunological processes are likely to be involved in the pathogenesis of Tourette’s syndrome (TS). To determine possible common underlying immunological mechanisms, we focused on innate immunity and studied markers of inflammation, monocytes, and monocyte-derived cytokines...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356225/ https://www.ncbi.nlm.nih.gov/pubmed/22471395 http://dx.doi.org/10.1186/1471-244X-12-29 |
_version_ | 1782233524672135168 |
---|---|
author | Matz, Judith Krause, Daniela L Dehning, Sandra Riedel, Michael Gruber, Rudolf Schwarz, Markus J Müller, Norbert |
author_facet | Matz, Judith Krause, Daniela L Dehning, Sandra Riedel, Michael Gruber, Rudolf Schwarz, Markus J Müller, Norbert |
author_sort | Matz, Judith |
collection | PubMed |
description | BACKGROUND: Infections and immunological processes are likely to be involved in the pathogenesis of Tourette’s syndrome (TS). To determine possible common underlying immunological mechanisms, we focused on innate immunity and studied markers of inflammation, monocytes, and monocyte-derived cytokines. METHODS: In a cross-sectional study, we used current methods to determine the number of monocytes and levels of C-reactive protein (CRP) in 46 children, adolescents, and adult patients suffering from TS and in 43 healthy controls matched for age and sex. Tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), soluble CD14 (sCD14), IL1-receptor antagonist (IL1-ra), and serum neopterin were detected by immunoassays. RESULTS: We found that CRP and neopterin levels and the number of monocytes were significantly higher in TS patients than in healthy controls. Serum concentrations of TNF-alpha, sIL1-ra, and sCD14 were significantly lower in TS patients. All measured values were within normal ranges and often close to detection limits. CONCLUSIONS: The present results point to a monocyte dysregulation in TS. This possible dysbalance in innate immunity could predispose to infections or autoimmune reactions. |
format | Online Article Text |
id | pubmed-3356225 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33562252012-05-19 Altered monocyte activation markers in Tourette’s syndrome: a case–control study Matz, Judith Krause, Daniela L Dehning, Sandra Riedel, Michael Gruber, Rudolf Schwarz, Markus J Müller, Norbert BMC Psychiatry Research Article BACKGROUND: Infections and immunological processes are likely to be involved in the pathogenesis of Tourette’s syndrome (TS). To determine possible common underlying immunological mechanisms, we focused on innate immunity and studied markers of inflammation, monocytes, and monocyte-derived cytokines. METHODS: In a cross-sectional study, we used current methods to determine the number of monocytes and levels of C-reactive protein (CRP) in 46 children, adolescents, and adult patients suffering from TS and in 43 healthy controls matched for age and sex. Tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), soluble CD14 (sCD14), IL1-receptor antagonist (IL1-ra), and serum neopterin were detected by immunoassays. RESULTS: We found that CRP and neopterin levels and the number of monocytes were significantly higher in TS patients than in healthy controls. Serum concentrations of TNF-alpha, sIL1-ra, and sCD14 were significantly lower in TS patients. All measured values were within normal ranges and often close to detection limits. CONCLUSIONS: The present results point to a monocyte dysregulation in TS. This possible dysbalance in innate immunity could predispose to infections or autoimmune reactions. BioMed Central 2012-05-18 /pmc/articles/PMC3356225/ /pubmed/22471395 http://dx.doi.org/10.1186/1471-244X-12-29 Text en Copyright ©2012 Matz et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Matz, Judith Krause, Daniela L Dehning, Sandra Riedel, Michael Gruber, Rudolf Schwarz, Markus J Müller, Norbert Altered monocyte activation markers in Tourette’s syndrome: a case–control study |
title | Altered monocyte activation markers in Tourette’s syndrome: a case–control study |
title_full | Altered monocyte activation markers in Tourette’s syndrome: a case–control study |
title_fullStr | Altered monocyte activation markers in Tourette’s syndrome: a case–control study |
title_full_unstemmed | Altered monocyte activation markers in Tourette’s syndrome: a case–control study |
title_short | Altered monocyte activation markers in Tourette’s syndrome: a case–control study |
title_sort | altered monocyte activation markers in tourette’s syndrome: a case–control study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356225/ https://www.ncbi.nlm.nih.gov/pubmed/22471395 http://dx.doi.org/10.1186/1471-244X-12-29 |
work_keys_str_mv | AT matzjudith alteredmonocyteactivationmarkersintourettessyndromeacasecontrolstudy AT krausedanielal alteredmonocyteactivationmarkersintourettessyndromeacasecontrolstudy AT dehningsandra alteredmonocyteactivationmarkersintourettessyndromeacasecontrolstudy AT riedelmichael alteredmonocyteactivationmarkersintourettessyndromeacasecontrolstudy AT gruberrudolf alteredmonocyteactivationmarkersintourettessyndromeacasecontrolstudy AT schwarzmarkusj alteredmonocyteactivationmarkersintourettessyndromeacasecontrolstudy AT mullernorbert alteredmonocyteactivationmarkersintourettessyndromeacasecontrolstudy |